Work

What Systemic Hormone Therapy Black Box Removal Means for Breast Cancer Survivors

Year: 2026

Type: article

Abstract: This Viewpoint discusses the benefits and risks of systemic hormone therapy in breast cancer survivors following the US Food and Drug Administration’s removal of black box warnings from menopausal hormone therapy.

Source: JAMA

DOI: 10.1001/jama.2026.0025

Authors: Versha Pleasant, Kari Ring

Institutions: University of Michigan, University of Virginia

Language: English

Topic: Menopause: Health Impacts and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Michigan Institute for Clinical and Health Research, National Center for Advancing Translational Sciences

Awards: G2318978926, G2491918497, G7792121194, Michigan Institute for Clinical and Health Research (MICHR)

OpenAlex ID: W7128060540

FWCI: 13.47

Cites: 10

Cited by: 3

Related to: